Literature DB >> 21374586

Altered expression of nerve growth factor and its receptors in the kidneys of diabetic rats.

Luigi Aloe1, Simona Rossi, Luigi Manni.   

Abstract

BACKGROUND: Type 1 diabetes (DB) is a multifactorial metabolic disorder characterized by loss of insulin-producing pancreatic ß-cells, and metabolic and functional deficits in a number of cells, including kidney cells. Nerve growth factor (NGF) is a signaling molecule that is up-regulated in cells affected by diabetes-linked disorders. However, whether DB alters the expression of NGF in the kidney is not known.
METHODS: DB was induced in adult male rats with a single injection of streptozotocin (STZ), and NGF protein levels were analyzed in a time-course study in serum and kidney. The expression of NGF receptors in the kidneys of healthy and DB rats was evaluated by immunohistochemistry. NGF levels as well as apoptotic features in the kidneys of healthy rats injected with purified NGF were also assessed.
RESULTS: This study revealed that DB elevates NGF levels in serum and NGF expression in the kidney and that subcutaneous administration of NGF causes a marked uptake of NGF in kidney cells. The elevated presence of NGF in kidney cells is not associated with proapoptotic factor expression.
CONCLUSIONS: The present data suggest that NGF presence in the kidney might play a survival, and most probably protective, role in kidney cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21374586     DOI: 10.5301/JN.2011.6418

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

1.  Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy.

Authors:  Riyaz Mohamed; Azza B El-Remessy
Journal:  J Clin Exp Ophthalmol       Date:  2015-10-25

2.  The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers.

Authors:  Elisavet K Tiaka; Nikolaos Papanas; Anastassios C Manolakis; Efstratios Maltezos
Journal:  Int J Burns Trauma       Date:  2011-09-03

3.  Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous.

Authors:  Sergio Zaccaria Scalinci; Lucia Scorolli; Giulia Corradetti; Daniela Domanico; Enzo Maria Vingolo; Alessandro Meduri; Mario Bifani; Duilio Siravo
Journal:  Clin Ophthalmol       Date:  2011-05-23

Review 4.  Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.

Authors:  Maha Coucha; Sally L Elshaer; Wael S Eldahshan; Barbara A Mysona; Azza B El-Remessy
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

5.  Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.

Authors:  B A Mysona; S Matragoon; M Stephens; I N Mohamed; A Farooq; M L Bartasis; A Y Fouda; A Y Shanab; D G Espinosa-Heidmann; A B El-Remessy
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

6.  Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.

Authors:  Zhe Wang; Jiali Wu; Zhaolan Hu; Cong Luo; Pengfei Wang; Yanling Zhang; Hui Li
Journal:  Oxid Med Cell Longev       Date:  2020-10-31       Impact factor: 6.543

7.  Stimulation of Neurite Outgrowth Using Autologous NGF Bound at the Surface of a Fibrous Substrate.

Authors:  Marta R Casanova; Rui L Reis; Albino Martins; Nuno M Neves
Journal:  Biomolecules       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.